CD69 and type 2 diabetes mellitus: To compare the effector responses of CD4 T cells to Mtb antigens in TB by T2D status, we stimulated PBMC with the Mtb300 antigen megapool and measured the expression of the activation markers CD69 and CD154 in combination with CD153.